Digital Health Global

JANUARY 25, 2024

Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. Debiopharm is headquartered in Lausanne, Switzerland, and will be presenting at the 7th Annual DDR Inhibition Conference in Boston from January 29-30, 2024.

Drug Development 88

Drug Development Digital Health 88

Digital Health Global

JANUARY 8, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI respectively. Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Digital Health Global

APRIL 10, 2023

Johnson Centre for Cancer Research at Queen’s University Belfast to spearhead development of the next generation of glyco-immune therapeutics. Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It CAMBRIDGE, Mass.–(BUSINESS

Life Science 88

Life Science BioTech Drug Development Health science 88

Society for Participatory Medicine

JANUARY 27, 2022

Clinical trials, care encounters, and access to data were found guilty of not meeting patients where they are and not adequately addressing the social determinant of health factors, creating barriers for patients. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.

BioTech 110

BioTech Life Science Drug Development Patient Experience 110

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 167

Drug Development Pharmaceuticals Life Science Digital Health 167

Digital Health Today

AUGUST 7, 2019

Some of the key topics discussed at the conference were collaboration with pharmaceuticals, adoption and engagement, business models, regulation and lots of concrete tips for entrepreneurs interested in launching a DTx on the market: Why are pharmaceuticals looking at DTx? The post Digital Therapeutics: the keys to succeed!

Pharmaceuticals 70

Pharmaceuticals Digital Health Drug Development Primary Care 70

The Digital Health Corner

MARCH 26, 2018

In this scenario, a patient can digitally determine who should have access to the medical record (and which portion), which person(s) or entities saw or modified the record (and what portion) and when. Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health.

Digital Health 117

Digital Health Interoperability Life Science Healthcare Data Security 117